{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T18:31:58Z","timestamp":1763058718425,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.suronc.2022.101754","type":"journal-article","created":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T02:16:07Z","timestamp":1651457767000},"page":"101754","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["A systematic review of axillary nodal irradiation for the management of the axilla in patients with early-stage breast cancer"],"prefix":"10.1016","volume":"42","author":[{"given":"F.","family":"Perera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3382-9371","authenticated-orcid":false,"given":"F.G.","family":"Baldassarre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.F.","family":"Eisen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Dayes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Engel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Cil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Kornecki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"George","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"SenGupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Brackstone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2014","series-title":"Issues in the Management of the Axilla in Patients with Breast Cancer. A Conversation with Hiram S. Cody III","author":"Piana","key":"10.1016\/j.suronc.2022.101754_bib1"},{"key":"10.1016\/j.suronc.2022.101754_bib2","doi-asserted-by":"crossref","unstructured":"Early Breast Cancer Trialists' Collaborative Group (EBCTCG), K. Albain, S. Anderson, R. Arriagada, W. Barlow, J. Bergh, J. Bliss, M. Buyse, D. Cameron, E. Carrasco, M. Clarke, C. Correa, A. Coates, R. Collins, J. Costantino, D. Cutter, J. Cuzick, S. Darby, N. Davidson, C. Davies, K. Davies, A. Delmestri, A. Di Leo, M. Dowsett, P. Elphinstone, V. Evans, M. Ewertz, R. Gelber, L. Gettins, C. Geyer, A. Goldhirsch, J. Godwin, R. Gray, C. Gregory, D. Hayes, C. Hill, J. Ingle, R. Jakesz, S. James, M. Kaufmann, A. Kerr, E. MacKinnon, P. McGale, T. McHugh, L. Norton, Y. Ohashi, S. Paik, H.C. Pan, E. Perez, R. Peto, M. Piccart, L. Pierce, K. Pritchard, G. Pruneri, V. Raina, P. Ravdin, J. Robertson, E. Rutgers, F.S.Y.S. Swain, C. Taylor, P. Valagussa, G. Viale, T. Whelan, E. Winer, Y. Wang, W. Wood, Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials, Lancet 378(9804) (2011) 1707-1716..","DOI":"10.1016\/S0140-6736(11)61629-2"},{"key":"10.1016\/j.suronc.2022.101754_bib3","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jclinepi.2015.06.005","article-title":"ROBIS: a new tool to assess risk of bias in systematic reviews was developed","volume":"69","author":"Whiting","year":"2016","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.suronc.2022.101754_bib4","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"Cochrane bias methods group, Cochrane statistical methods group, the Cochrane collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"author":"Sterne","key":"10.1016\/j.suronc.2022.101754_bib5"},{"issue":"7","key":"10.1016\/j.suronc.2022.101754_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001855","article-title":"Individual participant data (IPD) meta-analyses of randomised controlled trials: guidance on their use","volume":"12","author":"Tierney","year":"2015","journal-title":"PLoS Med."},{"year":"2013","series-title":"Handbook for Grading the Quality of Evidence and the Strength of Recommendations Using the GRADE Approach","key":"10.1016\/j.suronc.2022.101754_bib7"},{"key":"10.1016\/j.suronc.2022.101754_bib8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s40064-016-1712-9","article-title":"Axillary surgery in women with sentinel node-positive operable breast cancer: a systematic review with meta-analyses","volume":"5","author":"Schmidt-Hansen","year":"2016","journal-title":"SpringerPlus"},{"issue":"9935","key":"10.1016\/j.suronc.2022.101754_bib9","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/S0140-6736(14)60488-8","article-title":"Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials","volume":"383","author":"Early Breast Cancer Trialists\u2019 Collaborative Group","year":"2014","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.suronc.2022.101754_bib10","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJMoa1415369","article-title":"Internal mammary and medial supraclavicular irradiation in breast cancer","volume":"373","author":"Poortmans","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.suronc.2022.101754_bib11","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1056\/NEJMoa1415340","article-title":"Regional nodal irradiation in early-stage breast cancer","volume":"373","author":"Whelan","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.suronc.2022.101754_bib12","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.radonc.2011.07.007","article-title":"Adjuvant chemotherapy and radiotherapy in triple-negative breast carcinoma: a prospective randomized controlled multi-center trial","volume":"100","author":"Wang","year":"2011","journal-title":"Radiother. Oncol."},{"issue":"5","key":"10.1016\/j.suronc.2022.101754_bib13","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.clbc.2013.04.004","article-title":"Does the result of completion axillary lymph node dissection influence the recommendation for adjuvant treatment in sentinel lymph node-positive patients?","volume":"13","author":"Savolt","year":"2013","journal-title":"Clin. Breast Cancer"},{"issue":"12","key":"10.1016\/j.suronc.2022.101754_bib14","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial","volume":"15","author":"Donker","year":"2014","journal-title":"Lancet Oncol."},{"issue":"14","key":"10.1016\/j.suronc.2022.101754_bib15","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/j.ejca.2007.05.026","article-title":"Radiotherapy and tamoxifen after mastectomy in postmenopausal women - 20 year follow-up of the South Sweden Breast Cancer group randomised trial SSBCG II:I","volume":"43","author":"Killander","year":"2007","journal-title":"Eur. J. Cancer"},{"issue":"5","key":"10.1016\/j.suronc.2022.101754_bib16","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.breast.2009.09.006","article-title":"Efficient reduction of loco-regional recurrences but no effect on mortality twenty years after postmastectomy radiation in premenopausal women with stage II breast cancer - a randomized trial from the South Sweden Breast Cancer Group","volume":"18","author":"Killander","year":"2009","journal-title":"Breast"},{"issue":"9","key":"10.1016\/j.suronc.2022.101754_bib17","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/j.ejca.2013.02.017","article-title":"Comparison of the sentinel node procedure between patients with multifocal and unifocal breast cancer in the EORTC 10981-22023 AMAROS Trial: identification rate and nodal outcome","volume":"49","author":"Donker","year":"2013","journal-title":"Eur. J. Cancer"},{"issue":"4","key":"10.1016\/j.suronc.2022.101754_bib18","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer patients: 10 year follow up results of the EORTC AMAROS trial (EORTC 10981\/22023)","volume":"79","author":"Rutgers","year":"2019","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.suronc.2022.101754_bib19","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1016\/j.ejso.2016.06.088","article-title":"Optimal treatment of the axilla after positive sentinel lymph node biopsy in primary invasive breast cancer: OTOASOR Trial, a randomized, single centre, phase III, non-inferiority trial","volume":"42","author":"Savolt","year":"2016","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.suronc.2022.101754_bib20","series-title":"18F-FDG PET\/CT in the Follow-Up of Breast Cancer Patients with Positive SLN without ALND","first-page":"A3","author":"Savolt","year":"2011"},{"issue":"4","key":"10.1016\/j.suronc.2022.101754_bib21","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.ejso.2016.12.011","article-title":"Eight-year follow up result of the OTOASOR trial: the Optimal Treatment of the Axilla - surgery or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: a randomized, single centre, phase III, non-inferiority trial","volume":"43","author":"Savolt","year":"2017","journal-title":"Eur. J. Surg. Oncol."},{"issue":"13","key":"10.1016\/j.suronc.2022.101754_bib22","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1016\/j.ejca.2014.04.033","article-title":"Increased cardio and cerebrovascular mortality in breast cancer patients treated with postmastectomy radiotherapy--25 year follow-up of a randomised trial from the South Sweden Breast Cancer Group","volume":"50","author":"Killander","year":"2014","journal-title":"Eur. J. Cancer"},{"issue":"4","key":"10.1016\/j.suronc.2022.101754_bib23","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.ejso.2016.12.011","article-title":"Eight-year follow up result of the OTOASOR trial: the Optimal Treatment of the Axilla - surgery or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: a randomized, single centre, phase III, non-inferiority trial","volume":"43","author":"Savolt","year":"2017","journal-title":"Eur. J. Surg. Oncol."},{"issue":"6","key":"10.1016\/j.suronc.2022.101754_bib24","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/jso.24551","article-title":"Post-mastectomy radiation therapy and overall survival after neoadjuvant chemotherapy","volume":"115","author":"Kantor","year":"2017","journal-title":"J. Surg. Oncol."},{"issue":"5","key":"10.1016\/j.suronc.2022.101754_bib25","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/annonc\/mdw046","article-title":"The impact of postmastectomy and regional nodal radiation after neoadjuvant chemotherapy for clinically lymph node-positive breast cancer: a National Cancer Database (NCDB) analysis","volume":"27","author":"Rusthoven","year":"2016","journal-title":"Ann. Oncol."},{"issue":"17","key":"10.1016\/j.suronc.2022.101754_bib26","doi-asserted-by":"crossref","first-page":"24848","DOI":"10.18632\/oncotarget.6664","article-title":"The role of postmastectomy radiotherapy in clinically node-positive, stage II-III breast cancer patients with pathological negative nodes after neoadjuvant chemotherapy: an analysis from the NCDB","volume":"7","author":"Liu","year":"2016","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.suronc.2022.101754_bib27","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1245\/s10434-019-07635-x","article-title":"Post-mastectomy radiotherapy after neoadjuvant chemotherapy in breast cancer: a pooled retrospective analysis of three prospective randomized trials","volume":"26","author":"Krug","year":"2019","journal-title":"Ann. Surg Oncol."},{"issue":"15","key":"10.1016\/j.suronc.2022.101754_bib28","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1016\/j.ejca.2013.05.007","article-title":"High Ki67 predicts unfavourable outcomes in early breast cancer patients with a clinically clear axilla who do not receive axillary dissection or axillary radiotherapy","volume":"49","author":"Zurrida","year":"2013","journal-title":"Eur. J. Cancer"},{"issue":"5","key":"10.1016\/j.suronc.2022.101754_bib29","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1200\/JCO.2008.21.7554","article-title":"Role of axillary clearance after a tumor-positive sentinel node in the administration of adjuvant therapy in early breast cancer","volume":"28","author":"Straver","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.suronc.2022.101754_bib30","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1245\/s10434-010-0945-z","article-title":"Sentinel node identification rate and nodal involvement in the EORTC 10981-22023 AMAROS trial","volume":"17","author":"Straver","year":"2010","journal-title":"Ann. Surg Oncol."},{"issue":"12","key":"10.1016\/j.suronc.2022.101754_bib31","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/S1470-2045(20)30472-1","article-title":"Internal mammary and medial supraclavicular lymph node chain irradiation in stage I\u2013III breast cancer (EORTC 22922\/10925): 15-year results of a randomised, phase 3 trial","volume":"21","author":"Poortmans","year":"2020","journal-title":"Lancet Oncol."},{"issue":"27","key":"10.1016\/j.suronc.2022.101754_bib32","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1200\/JCO.21.00934","article-title":"Management of the axilla in early-stage breast cancer: Ontario Health (cancer Care Ontario) and ASCO guideline","volume":"39","author":"Brackstone","year":"2021","journal-title":"J. Clin. Oncol."}],"container-title":["Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960740422000470?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960740422000470?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T03:21:28Z","timestamp":1760757688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960740422000470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":32,"alternative-id":["S0960740422000470"],"URL":"https:\/\/doi.org\/10.1016\/j.suronc.2022.101754","relation":{},"ISSN":["0960-7404"],"issn-type":[{"type":"print","value":"0960-7404"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic review of axillary nodal irradiation for the management of the axilla in patients with early-stage breast cancer","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.suronc.2022.101754","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101754"}}